ANNX

Conviction 64HealthcareScan · Mon, Aug 10, 2026

ANNX$5.40-0.18%

ResistanceSupportVol 14Insider buy

Vol MA14 3.06M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Annexon, Inc.PHARMACEUTICAL PREPARATIONSwww.annexonbio.com ↗

Price5.40

Change-0.18%

Gap-0.18%

Rel volume3.43×

Avg volume3.68M

Avg $ vol20.37M

SMA 205.41

SMA 505.36

SMA 2005.19

Price vs 50+0.66%

Price vs 200+3.96%

MA stackbullish

50/200 cross—

Supertrenddown · 6.13

RSI (14)50

MACD hist0.02

MACD crossbull · 2d

Stoch %K / %D68 / 70

ADX (14)16

+DI / −DI25 / 19

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.67%

ADR %7.21%

52w high6.96

52w low2.05

From 52w high-22.41%

Above 52w low+163.41%

New 52w highNo

SqueezeOff

Bollinger width25.94%

%B0.50

Donchian pos35.16%

Donchian high6.58

Donchian low4.76

AVWAP (52w high)5.55

vs AVWAP high-2.69%

AVWAP (52w low)4.98

vs AVWAP low+8.47%

OBV trendDown

Chaikin MF (20)-0.00

Today vs 20d3.43×

Avg vol (14d)3.06M

Avg vol (20d)3.68M

Avg $ vol (20d)20.37M

Market cap208.24M

RS 3m (vs SPY)-7.69%

RS 6m (vs SPY)-18.02%

RS line new highNo

Trend template5/8

Technical rank38.8

1 week+2.86%

1 month-6.90%

3 months-5.10%

6 months-5.76%

1 year+127.85%

YTD+15.14%

P/E-1.01

P/B1.02

P/S—

P/FCF-1.12

EPS-1.34

Div yield—

ROE-101.05%

ROA-78.62%

Debt/Eq—

Current6.35

EV/EBITDA-0.15

Gross margin—

Net margin—

Rev growth—

EPS growth-49.56%

Price target15.20

Target upside181.48%

Analyst ratingBuy

Institutional104.07%

Ent. value33.04M

Revenue—

Net income-44.14M

Gross profit—

Free cash flow-186.49M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out163.84M

Employees93

ListedFri, Jul 24, 2020

Free float86.06M

Float %71.9%

Short interest29.83M

Days to cover5.7d

Short volume49.1%

Squeeze score86 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs −$0.30

Last surprise+23.3% beat

Setup gradeB

Conviction64 / 100

Pattern quality—

Tech rank38.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.55

Support4.61

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Breaking out now
Jul 15
1 scan
→
Setting up
Jul 16
1 scan

Congress activity

Disclosed STOCK Act trades in ANNX

All disclosures →

No recent disclosed trades by Congress in ANNX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANNX · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Satter Muneer A Director · Common Stock · 2026-05-28	Buy	613.5K	$3.3M	2026-05-28	2026-05-29
Carson William H. Director · Common Stock · 2026-05-11	Buy	8K	$46K	2026-05-11	2026-05-13
Carson William H. Director · Common Stock · 2026-04-10	Buy	8K	$50K	2026-04-10	2026-04-14

SEC filings

EDGAR filings in ANNX · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.